IBL positivity was found to be 40.5% for Pseudomonas aeruginosa, and 20% for Enterobacter aerogenes.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:In our study, a total of 281 Gram negative bacilli obtained from patients in the surgical and coronary intensive care units were investigated the production of inducible beta lactamases (IBLs).
📊
Key Findings & Data:For IBLs, the double disk induction methods was used.
💡
Conclusion & Impact:IBL positivity was found to be 40.5% for Pseudomonas aeruginosa, and 20% for Enterobacter aerogenes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
In our study, a total of 281 Gram negative bacilli obtained from patients in the surgical and coronary intensive care units were investigated the production of inducible beta lactamases (IBLs). For IBLs, the double disk induction methods was used. IBL positivity was found to be 40.5% for Pseudomonas aeruginosa, and 20% for Enterobacter aerogenes.
Özet
Çalışmamızda, cerrahi ve koroner yoğun bakım ünitelerinde yatan hastalardan elde edilen 281 Gram negatif çomakta indüklenebilir beta-laktamaz (İBL) varlığı araştırılmıştır. Bunun için çift disk indüksiyon yöntemi kullanılmıştır. İBL pozitifliği Pseudomonas aeruginosa suşlarında %40,5 ve Enterobacter aerogenes suşlarında da %20 olarak saptanmıştır.
🔖
Cite This Article
KÜÇÜKATEŞ, E., GÜLTEKİN, N., KANSIZ, E. (2022). Investigation of inducible beta-lactamases in the Gram negative bacilli isolated from patients in the intensive care units. Türk Mikrobiyoloji Cemiyeti Dergisi, Cilt: 37 - Sayı: 3, 138–141. https://ajindex.com/articles/636023
Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP. Inducible amp C β-lactamase producing Gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 1997; 28:211
Fihman V, Rottman M, Benzerara Y, Delisle F, Labia R, Philippon A, Arlet G. BUT-1: a new member in the chromosomal inducible class C β-lactamases family from a clinical isolate of Buttiauxella sp.FEMS Microbiol Lett 2002;213:103
Gülay Z. indüklenebilir beta-laktamazlar; özellikleri, epidemiyolojisi ve klinik önemi, “Ulusoy S (editör): Beta laktamazlar ve Klinik Önemi”, Mezuniyet Sonrası Eğitim Dizisi, s-45, Bilimsel T›p Yayınları, Ankara, 2005
Pfaller MA, Jones RN. MYSTIC Study Group (Europe). Antimicrobial susceptibility of inducible AmpC β-lactamaseproducing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents 2002;19:383
Koneman EW, Allen SD, Jonda WM, Schreckenberger PC, Winn WC. Color Atlas and Textbook of Diagnostic Microbiology, 5th. JB Lippincott Co, Philadelphia, 1997
Philips I. British Society for Antimicrobial Chemotherapy Party Working A guide to sensitivity testing. J Antimicrob Chemother 1991;37:1
Bal Ç. Beta-laktamaz testleri ve rutinde kullan›mlar›. In: Gür D, Söyletir G, Bal Ç, Dündar V, Sümerkan B, Köksal i, Çiftçi U, (ed). Türk Mikrobiyoloji Cemiyeti Antibiyotik Duyarlılık Testlerinin Standardizasyonu (ADTS) Çal›flma Grubu. Antibiyotik Duyarlılık Testlerinin Standardizasyonu Toplantısı kitabında. s.101. İstanbul, Türk Mikrobiyoloji Cemiyeti, 1997
Dietz H, Pfeifle D, Wiedemann B. The signal molecule for β-lactamase induction in Enterobacter cloacae is the anhydromuramyl- pentapeptide.Antimicrob Agents Chemother 1997; 41:2113
Jacobs C, Frere JM, Normark S. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in Gram-negative bacteria. Cell 1997;88:823
Honore N, Nicolas MH, Cole ST. Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EMBO J 1986;5:3709